CODX Insider Trading
Insider Ownership Percentage: 6.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Co-Diagnostics Insider Trading History Chart
This chart shows the insider buying and selling history at Co-Diagnostics by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Co-Diagnostics Share Price & Price History
Current Price: $0.80
Price Change: ▲ Price Increase of +0.0196 (2.53%)
As of 01/17/2025 05:00 PM ET
Co-Diagnostics Insider Trading History
Co-Diagnostics Institutional Trading History
Data available starting January 2016
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Read More on Co-Diagnostics
Volume
74,478 shs
Average Volume
310,081 shs
Market Capitalization
$25.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of Co-Diagnostics?